These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3490424)

  • 1. Phenotypic heterogeneity displayed by T-non Hodgkin's lymphoma (T-NHL) cells dispersed from diagnostic lymph node biopsies.
    Jones DB; Wright DH; Paul F; Smith JL
    Hematol Oncol; 1986; 4(3):219-26. PubMed ID: 3490424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between histology and immunophenotype in a series of 322 cases of non-Hodgkin's lymphoma.
    Smith JL; Jones DB; Bell AJ; Wright DH
    Hematol Oncol; 1989; 7(1):37-48. PubMed ID: 2642457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD).
    Jacob MC; Favre M; Lemarc'Hadour F; Sotto MF; Bonnefoix T; Sotto JJ; Bensa JC
    Am J Hematol; 1992 Jan; 39(1):45-51. PubMed ID: 1531569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic analysis by flow cytometry of surface immunoglobulin light chains and B and T cell antigens in lymph nodes involved with non-Hodgkin's lymphoma.
    Liendo C; Danieu L; Al-Katib A; Koziner B
    Am J Med; 1985 Oct; 79(4):445-54. PubMed ID: 3931469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
    Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
    Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of T-cell subsets identified by monoclonal antibodies in cell suspensions from lymph node biopsies of human B-cell lymphomas.
    Kvaløy S; Marton PF; Høst H; Solheim BG; Godal T
    Scand J Haematol; 1982 Apr; 28(4):293-305. PubMed ID: 6981200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the T1 (CD5, p67) surface antigen in B-CLL and B-NHL and its correlation with other B-cell differentiation markers.
    Delia D; Bonati A; Giardini R; Villa S; De Braud F; Cattoretti G; Rilke F
    Hematol Oncol; 1986; 4(3):237-48. PubMed ID: 3095211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of human MHC class II antigens in B-cell non-Hodgkin's lymphomas.
    Krajewski AS; Guy K; Dewar AE; Cossar D
    J Pathol; 1985 Feb; 145(2):185-94. PubMed ID: 2579225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunocytochemical study of T-cell lymphomas using monoclonal and polyclonal antibodies effective in routinely fixed wax embedded tissues.
    Norton AJ; Isaacson PG
    Histopathology; 1986 Dec; 10(12):1243-60. PubMed ID: 3546052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
    Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
    Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodular lymphocyte predominance type of Hodgkin's disease is a B cell lymphoma.
    Poppema S; Timens W; Visser L
    Adv Exp Med Biol; 1985; 186():963-9. PubMed ID: 2931963
    [No Abstract]   [Full Text] [Related]  

  • 12. Cutaneous involvement by angioimmunoblastic T-cell lymphoma with remarkable heterogeneous Epstein-Barr virus expression.
    Brown HA; Macon WR; Kurtin PJ; Gibson LE
    J Cutan Pathol; 2001 Sep; 28(8):432-8. PubMed ID: 11493382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-lymphocyte subpopulations in B-cell-derived non-Hodgkin's lymphomas and Hodgkin's disease.
    Knowles DM; Halper JP; Jakobiec FA
    Cancer; 1984 Aug; 54(4):644-51. PubMed ID: 6234982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Hodgkin's lymphoma phenotyping: problems in the use of heterologous and monoclonal antibodies.
    Barcos M; Minowada J; Minato K; Pollard C; Cancino M; Han T; Henderson E; Ozer H
    Leuk Res; 1983; 7(4):523-37. PubMed ID: 6604849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear antigens in neoplastic lymphocytes of B cell and T cell non-Hodgkin's lymphomas.
    Dardick I; Hall R; Bailey DJ; Stratis M; Brown DL; Chaly N
    Am J Pathol; 1989 Jan; 134(1):213-22. PubMed ID: 2783638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma.
    Guy K; Krajewski AS; Dewar AE
    Br J Cancer; 1986 Feb; 53(2):161-73. PubMed ID: 3513812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistocytochemical correlation of DAP IV-CD 26 reactivity with immunologic markers of lymphocyte activation in human lymphoid tissues.
    Cozzi M; Gloghini A; Volpe R; Carbone A
    Br J Haematol; 1990 Jul; 75(3):325-32. PubMed ID: 1974815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonlymphoblastic T-cell lymphoma in children.
    Bitter MA; Nachman J; Jones N; Franklin WA; Le Beau MM; Vardiman JW
    Cancer; 1987 Jun; 59(12):2099-103. PubMed ID: 3494500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of immunocytochemical staining of lymph node aspirates in diagnostic cytology.
    Oertel J; Oertel B; Kastner M; Lobeck H; Huhn D
    Br J Haematol; 1988 Nov; 70(3):307-16. PubMed ID: 3061442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.
    Conlan MG; Bast M; Armitage JO; Weisenburger DD
    J Clin Oncol; 1990 Jul; 8(7):1163-72. PubMed ID: 1694234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.